Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer.

作者: A Ooki , K Yamashita , S Kikuchi , S Sakuramoto , N Katada

DOI: 10.1038/ONC.2010.76

关键词:

摘要: HOP homeobox (HOPX) is an unusual gene encoding three spliced transcript variants, among which the only HOPX-β promoter harbors CpG islands. The characteristics of its methylation was analyzed using bisulfite sequencing and quantitative-methylation-specific polymerase chain reaction (Q-MSP), effects HOPX expression were also examined. silenced in all gastric cancer cell lines tested; could be restored by treatment with demethylating agent. On Q-MSP, hypermethylation (cut-off value 3.55) found 84% (67 out 80) primary tumor tissues 10% (8 corresponding normal discriminate from (P<0.0001). prognosis advanced cases as poor those stage IV disease when cut-off set at 11.28. This finding validated independent cohort 90 cancers. prognostic factor (P=0.029) on multivariate analysis. Exogenous significantly inhibited proliferation, colony formation invasion well enhanced apoptosis. Taken together, a frequent cancer-specific event cancer. Quantitative assessment has great clinical potential marker aggressiveness.

参考文章(39)
胃癌研究会, Japanese classification of gastric carcinoma Kanehara & Co.. ,(1995)
Elizabeth E. Cameron, Kurtis E. Bachman, Sanna Myöhänen, James G. Herman, Stephen B. Baylin, Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Nature Genetics. ,vol. 21, pp. 103- 107 ,(1999) , 10.1038/5047
Yutaka Tokumaru, Keishi Yamashita, Myoung Sook Kim, Hannah L. Park, Motonobu Osada, Masaki Mori, David Sidransky, The role of PGP9.5 as a tumor suppressor gene in human cancer International Journal of Cancer. ,vol. 123, pp. 753- 759 ,(2008) , 10.1002/IJC.23354
Jinah Park, Sang-Hyun Song, Tai Young Kim, Moon-Chang Choi, Hyun-Soon Jong, Tae-You Kim, Jung Weon Lee, Noe Kyeong Kim, Woo-Ho Kim, Yung-Jue Bang, Aberrant methylation of integrin α4 gene in human gastric cancer cells Oncogene. ,vol. 23, pp. 3474- 3480 ,(2004) , 10.1038/SJ.ONC.1207470
Peter W. Laird, The power and the promise of DNA methylation markers Nature Reviews Cancer. ,vol. 3, pp. 253- 266 ,(2003) , 10.1038/NRC1045
Takao Takahashi, Makoto Suzuki, Hisayuki Shigematsu, Narayan Shivapurkar, Chinyere Echebiri, Masaharu Nomura, Victor Stastny, Meena Augustus, Chew‐Wun Wu, Ignacio I. Wistuba, Stephen J. Meltzer, Adi F. Gazdar, Aberrant methylation of Reprimo in human malignancies. International Journal of Cancer. ,vol. 115, pp. 503- 510 ,(2005) , 10.1002/IJC.20910
Kunitoshi Tomii, Kazunori Tsukuda, Shinichi Toyooka, Hideaki Dote, Tadashi Hanafusa, Hiroaki Asano, Minoru Naitou, Hiroyoshi Doihara, Takumi Kisimoto, Hideki Katayama, Harvery I. Pass, Hiroshi Date, Nobuyoshi Shimizu, Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers. International Journal of Cancer. ,vol. 120, pp. 566- 573 ,(2007) , 10.1002/IJC.22341
Keishi Yamashita, Hannah Lui Park, Myoung Sook Kim, Motonobu Osada, Yutaka Tokumaru, Hiroshi Inoue, Masaki Mori, David Sidransky, PGP9.5 methylation in diffuse-type gastric cancer. Cancer Research. ,vol. 66, pp. 3921- 3927 ,(2006) , 10.1158/0008-5472.CAN-05-1511
Toshifusa Nakajima, Gastric cancer treatment guidelines in Japan. Gastric Cancer. ,vol. 5, pp. 1- 5 ,(2002) , 10.1007/S101200200000